Cohen & Steers Global Realty Majors ETF

Cohen & Steers Global Realty Majors ETF Stock Forecast & Price Prediction

Live Cohen & Steers Global Realty Majors ETF Stock (GRI) Price
$0.5

0

Ratings

  • Buy 0
  • Hold 0
  • Sell 0
Disclaimer : Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance. This information is for educational purposes only and should not be construed as advice to buy or sell any security.

Stock Price

$0.5

P/E Ratio

0.01

Volume Traded Today

$90,946

Dividend

$0.511

52 Week High/low

188.37/0.40

Cohen & Steers Global Realty Majors ETF Market Cap

$1.7M

๐Ÿ›‘ Alert: These ten stocks could have higher potential than $GRI ๐Ÿ›‘

Before you buy GRI you'll want to see this list of ten stocks that have huge potential. Want to see if GRI made the cut? Enter your email below

GRI Summary

Based on ratings from 0 stock analysts, the Cohen & Steers Global Realty Majors ETF stock price is expected to decrease by 100% in 12 months. This is calculated by using the average 12-month stock price forecast for Cohen & Steers Global Realty Majors ETF. The lowest target is $ and the highest is $. Please note analyst price targets are not guaranteed and could be missed completely.

GRI Analyst Ratings

Cohen & Steers Global Realty Majors ETF has a total of 0 Wall St Analyst ratings. There are 0 buy ratings, 0 ratings, and 0 sell ratings. Since most analysts have a sell consensus rating, the expectation is that Cohen & Steers Global Realty Majors ETF will perform worse than the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.

GRI stock forecast by analyst

These are the latest 20 analyst ratings of GRI.

Analyst/Firm

Rating

Price Target

Change

Date

Data Not Found!

GRI Company Information

  • Company Name: GRI Bio, Inc. (formerly Glycoregimmune, Inc.)
  • Industry: Clinical-stage biopharmaceutical company
  • Focus: Discovering, developing, and commercializing therapies for inflammatory, fibrotic, and autoimmune disorders
  • Lead Product Candidate: GRI-0621 - an oral inhibitor targeting type 1 Natural Killer T cells
  • Clinical Status: GRI-0621 is in Phase II clinical trials for severe fibrotic lung diseases, including idiopathic pulmonary fibrosis
  • Other Products:
    • GRI-0803 - a novel oral agonist of type 2 Natural Killer T cells in preclinical development for autoimmune disorders
    • GRI-0124 - for the treatment of primary sclerosing cholangitis, in preclinical development
    • GRI-0729 - also in preclinical development
    • Proprietary library of 500+ compounds
  • Founded: 2009
  • Headquarters: La Jolla, California
GRI
Cohen & Steers Global Realty Majors ETF (GRI)

When did it IPO

2021

Staff Count

4

Country

United States

Sector/Industry

Healthcare/Biotechnology

CEO

Dr. W. Marc Hertz Ph.D.

Market Cap

$1.7M

Cohen & Steers Global Realty Majors ETF (GRI) Financial Data

In 2023, GRI generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that GRI's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.

Revenue From 2020

N/A

Revenue From 2021

$0

0.00 %
From Previous Year

Revenue From 2022

$0

0.00 %
From Previous Year

Revenue From 2023

$0

0.00 %
From Previous Year
  • Revenue TTM $0
  • Operating Margin TTM 0.0%
  • Gross profit TTM $0
  • Return on assets TTM -82.5%
  • Return on equity TTM -189.1%
  • Profit Margin 0.0%
  • Book Value Per Share 5.89%
  • Market capitalisation $1.7M
  • Revenue for 2021 $0
  • Revenue for 2022 $0
  • Revenue for 2023 $0
  • EPS this year (TTM) $52.36

Cohen & Steers Global Realty Majors ETF (GRI) Latest News

No news data available.

...

GRI Frequently asked questions

The highest forecasted price for GRI is $ from at .

The lowest forecasted price for GRI is $ from from

The GRI analyst ratings consensus are 0 buy ratings, 0 hold ratings, and 0 sell ratings.